VirginiaSB2712026 Regular SessionSenate

Prescription Drug Affordability Board; established.

Sponsored By: R. Creigh Deeds (Democratic)

Passed

Summary

Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to HB 483.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • R. Creigh Deeds

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 248 • No: 34

Senate vote 4/22/2026

Passed by for the day (Voice Vote)

Yes: 0 • No: 0

Senate vote 3/11/2026

House substitute agreed to by Senate

Yes: 32 • No: 8

House vote 3/10/2026

Passed House with substitute

Yes: 95 • No: 4

House vote 3/4/2026

Reported from Appropriations

Yes: 17 • No: 5

Senate vote 2/6/2026

Read third time and passed Senate

Yes: 31 • No: 8

Senate vote 2/5/2026

Commerce and Labor Amendments agreed to

Yes: 0 • No: 0

Senate vote 2/4/2026

Constitutional reading dispensed Block Vote (on 1st reading)

Yes: 40 • No: 0

Senate vote 2/4/2026

Passed by for the day Block Vote (Voice Vote)

Yes: 0 • No: 0

Senate vote 2/3/2026

Reported from Finance and Appropriations

Yes: 9 • No: 5 • Other: 1

Senate vote 1/26/2026

Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations

Yes: 10 • No: 4 • Other: 1

Senate vote 1/22/2026

Rereferred from Education and Health to Commerce and Labor

Yes: 14 • No: 0

Actions Timeline

  1. Passed by for the day (Voice Vote)

    4/22/2026Senate
  2. Governor's Action Deadline 11:59 p.m., May 23, 2026

    4/22/2026Governor
  3. Communicated to Governor

    4/22/2026Senate
  4. Governor's recommendation received by Senate

    4/13/2026Governor
  5. Fiscal Impact Statement from Department of Planning and Budget (SB271)

    3/31/2026Senate
  6. Governor's Action Deadline 11:59 p.m., April 13, 2026

    3/31/2026Governor
  7. Enrolled Bill communicated to Governor on March 31, 2026

    3/31/2026Senate
  8. Signed by Speaker

    3/31/2026House
  9. Bill text as passed Senate and House (SB271ER)

    3/30/2026Senate
  10. Enrolled

    3/30/2026Senate
  11. Signed by President

    3/30/2026Senate
  12. Fiscal Impact Statement from Department of Planning and Budget (SB271)

    3/23/2026Senate
  13. House substitute agreed to by Senate

    3/11/2026Senate
  14. Passed House with substitute (95-Y 4-N 0-A)

    3/10/2026House
  15. Engrossed by House - floor substitute

    3/10/2026House
  16. Delegate Delaney Floor substitute agreed to

    3/10/2026House
  17. Delegate Delaney Floor amendments withdrawn

    3/10/2026House
  18. Delegate Delaney Substitute withdrawn by House

    3/10/2026House
  19. Read third time

    3/10/2026House
  20. Floor Offered

    3/10/2026House
  21. Floor substitute printed 26109555D-H2 (Delaney)

    3/10/2026House
  22. Passed by for the day

    3/9/2026House
  23. Passed by temporarily

    3/9/2026House
  24. Read third time

    3/9/2026House
  25. Floor Offered

    3/9/2026House

Bill Text

Related Bills

Back to State Legislation